The Weak Evidence Behind ‘Gender-Affirming Care’ for Children

The Endocrine Society is ignoring the dangers that sex-change treatments pose to minors.

Stephen Hammes’s response (Letters, July 5) to our op-ed (“The Endocrine Society’s Dangerous Transgender Politicization,” June 29) proves our point: The Endocrine Society is ignoring the dangers that sex-change treatments pose to children.

Dr. Hammes, president of the Endocrine Society, leaves out that the society’s pro-sex-change guidelines are based on “low” or “very low” quality evidence. He says nothing about the growing number of progressive European countries that are abandoning America’s model of gender-affirming care following systematic reviews of the evidence.

Read more at The Wall Street Journal.